Mikart is a pioneering company in the biotechnology, manufacturing, and pharmaceutical industries, with a foundation built on delivering quality services along with speed and responsiveness, encapsulated in their slogan "Solid Foundation Flexible Solutions". Established in 1975, Mikart specializes in solid oral and liquid oral dosage forms - offering a full range of integrated services, technology, and support for the development, manufacturing, and packaging of solid dose and non-sterile liquid pharmaceuticals. Their clientele includes prominent names such as PhRMA, specialty pharma, and biotech companies, all of whom benefit from Mikart’s scientific and technical expertise, accompanied by personalized solutions and responsive service. As a Contract Development and Manufacturing Organization (CDMO), Mikart stands out for its ability to fast-track the process of bringing products to market. While specific investment details are not available, their track record of reputable clients and steadfast industry presence make them an intriguing prospect for venture capitalists seeking exposure to the pharmaceutical and biotechnology sectors. With their headquarters based in the United States, Mikart presents a compelling package of expertise and market potential for potential investors navigating the life sciences space.
There is no investment information
No recent news or press coverage available for Mikart, LLC.